Bertie
search
auto_awesomeActioninventory_2Consultant review
Action 3 · Task 143 · Group 7

Evaluate Funding Fit Against Venture Strategy Criteria

The founder benchmarks the proposed non-dilutive funding stack against the venture's core strategic milestones, technical roadmap, and IP strategy. They evaluate whether pursuit of specific grants will divert engineering capacity away from high-priority commercial deliverables. This ensures capital acquisition supports, rather than dictates, venture strategy.

Objective

Completing this action tests whether the non-dilutive strategy actively accelerates core venture objectives or merely pursues soft capital at the expense of speed. It protects the venture's focus by ensuring public funding aligns with existing product roadmaps rather than creating opportunistic distractions.

What's expected from the founder

A formal alignment matrix scoring each grant or tax incentive against core strategic milestones, technical roadmaps, and IP ownership criteria. The founder must document clear justifications where project scopes have been modified to fit grant calls.

psychologyBertie consultant stress-test

Five questions an expert would ask when reviewing your output

Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.

  1. 1

    How much engineering effort is being redirected to satisfy grant scope requirements that sit outside your core commercial roadmap?

  2. 2

    What evidence demonstrates that your intellectual property strategy remains fully protected when partnering with academic or industrial co-applicants?

  3. 3

    Why are you pursuing high-friction public grants if the required deliverables slow down your speed to commercial market fit?

  4. 4

    How do the reporting and administrative overheads of this specific grant scheme compare to the net capital it introduces?

  5. 5

    Where does the proposed funding timeline conflict with the critical product launch dates recorded in your venture DNA?